Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
  1. 4 Option exercise Director acquired 2,000 shares (option exercise)
  2. 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $18.58 ($167,220)
  3. 4 Planned sale President/CEO and Board Chair sold 3,100 shares at $20.01 ($62,031)
  4. 4 Planned sale Chief Commercial Officer sold 100 shares at $20.00 ($2,000)
  5. 4 Planned sale Chief Commercial Officer sold 4,643 shares at an average $19.00 ($88,231)
  6. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $15.90 ($127,200)
  7. 4 Other disposition Director disposed of 215,576 shares (other)
  8. 4 Planned sale President/CEO and Board Chair sold 9,000 shares at $16.80 ($151,200)
  9. 4 Planned sale President/CEO and Board Chair sold 10,119 shares at an average $15.11 ($152,925)
  10. 3/A Insider 3/A
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Planned sale President/CEO and Board Chair sold 2,311 shares at $15.03 ($34,734)
  14. 4 Planned sale Chief Financial Officer sold 5,000 shares at $14.02 ($70,100)
  15. 4 Planned sale President/CEO and Board Chair sold 8,000 shares at $13.60 ($108,800)
  16. 4 Open-market sale Chief Financial Officer sold 1,004 shares at an average $12.55 ($12,603)
  17. 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,513 shares at an average $12.58 ($19,026)
  18. 4 Open-market sale Chief Operating Officer sold 1,141 shares at an average $12.55 ($14,324)
  19. 4 Open-market sale General Counsel sold 1,078 shares at an average $12.55 ($13,532)
  20. 4 Open-market sale President/CEO and Board Chair sold 2,125 shares at an average $12.55 ($26,669)

Page 9 of 17 · 330 filings